We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Omega-3 Fatty Acid Reduces Amyloid Buildup

By Biotechdaily staff writers
Posted on 08 Apr 2005
Researchers studying Alzheimer's disease have found that enriching the diet with the omega-3 fatty acid docosahexenoic acid (DHA) significantly reduced amyloid plaque buildup.

Investigators at the University of California, Los Angeles (USA) worked with a mouse model genetically engineered to develop symptoms of Alzheimer's disease. More...
Aged animals (17-19 months old) were placed in one of three groups, which until 22.5 months received food enriched with different levels of DHA: controls (0.09% DHA), low-DHA group (0%), or high-DHA group (0.6%).


When the animals reached 22.5 months of age, their brains were scanned for image analysis, and then an enzyme-linked immunosorbent assay (ELISA) was used to measure the amount of DHA in the detergent-insoluble extract of cortical homogenates. Results published in the March 23, 2005, issue of the Journal of Neuroscience revealed that DHA-enriched diets significantly reduced total amyloid protein by more than 70% when compared with low-DHA or control chow diets. Image analysis of brain sections with an antibody against amyloid protein (amino acids 1-13) showed that overall plaque burden was significantly reduced by 40.3%, with the largest reductions (40-50%) in the hippocampus and parietal cortex.

These results suggest that dietary DHA, such as fish oil, could be protective against beta-amyloid production, accumulation, and potential downstream toxicity. "The good news from this study is that we can buy the therapy at a supermarket or drug store,” said senior author Dr. Greg M. Cole, professor of neurosciences at the University of California, Los Angeles. "DHA has a tremendous safety profile--essentially no side effects--and clinical trial evidence supports giving DHA supplements to people at risk for cardiovascular disease.”



Related Links:
University of California, Los Angeles

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Electrolyte Analyzer
BKE-B
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Longitudinal Heart Stress Assessment Improves Prediction of Cardiovascular Outcomes

Accurately predicting cardiovascular disease (CVD) risk in older adults is challenging when assessments rely on single, point-in-time biomarker measurements. Dynamic indicators that reflect evolving cardiac... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.